Switch to:
More From Other Websites
CEL-SCI Corporation Releases Letter to Shareholders May 24 2017
CEL-SCI Scientist Presents at AAI - IMMUNOLOGY 2017 Meeting May 16 2017
CEL-SCI Announces Change to the Date of Its Annual Meeting May 12 2017
Cel-Sci reports 2Q loss May 10 2017
CEL-SCI Corporation Reports Second Quarter Fiscal Year 2017 Financial Results May 10 2017
A Neurotrope Stock Promotion Scheme Is Underway, but Who's Paying for It? May 03 2017
CEL-SCI Announces $1.51 Million Registered Direct Offering May 01 2017
CEL-SCI Receives Intent to Grant Notice for New Multikine Patent from the European Patent Office Apr 28 2017
CEL-SCI Scientist Presents at the World Vaccine Congress Apr 12 2017
Blog Coverage CEL-SCI Provides Update on Late-stage Multikine Head and Neck Cancer Study Mar 08 2017
CEL-SCI Gives Update on Partial Clinical Hold on Phase 3 Head and Neck Cancer Study with Multikine Mar 06 2017
Vienna’s Cel-Sci Corp. raises $1 million for head and neck cancer trial Mar 01 2017
CEL-SCI Announces That the NYSE MKT Approves Plan Feb 27 2017
CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference Feb 21 2017
Cel-Sci posts 1Q profit Feb 09 2017
CEL-SCI Corporation Reports First Quarter Fiscal 2017 Financial Results Feb 09 2017
CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK